Curis Management Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Daniel R. Passeri Yes, thanks, Ali. Good morning, everyone. I’ll first begin with Erivedge, which is being developed and commercialized globally by Genentech and Roche under our existing collaboration…. more

View todays social media effects on CRIS

View the latest stocks trending across Twitter. Click to view dashboard

See who Curis is hiring next, click here to view